Skip to main content

Advertisement

Table 1 Baseline characteristics of patients.

From: Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection

Subject ID Age Sex Blood CD4+ CDC Stage ADC Stage HIV-1 RNA Antiretroviral therapies
    baseline (nadir)    CSF Plasma  
  (years)   (cells/μL)    (log 10 copies/ml)  
San Francisco
6004 56 M 275 (116) B3 0 <1.29 4,11 d4T,3TC,IDV
6008 39 M 834 (360) A2 0 1,61 <1.29 SQV, RTV
6011 47 M 375 (191) B3 0,5 <1.29 1,41 ZDV, 3TC, EFV
6012 54 M 464 (199) B3 0 <1.29 1,57 d4T, 3TC, EFV
6013 44 M 618 (275) C2 0 <1.29 3,69 d4T, 3TC, EFV
Göteborg
160 51 M 544 (195) C3 0 <1.29 <1.29 ZDV, 3TC, IDV
207 47 M 428 (210) A2 0 <1.29 <1.29 ZDV, 3TC, SQV, NFV
223 56 F 365 (110) B3 0 <1.29 <1.29 ZDV, 3TC, IDV/RTV